Table 1 Patient demographics
From: Poxvirus-based vaccine therapy for patients with advanced pancreatic cancer
Characteristics | N = 10 |
|---|---|
Mean (range) age, years | 57.9 ± 9.6 (43–74) |
Performance status*, n (%) | Â |
   80% | 4 (40) |
   90% | 3 (30) |
   100% | 3 (30) |
Sex, n (%) | Â |
   Male | 7 (70) |
   Female | 3 (30) |
Race, n (%) | Â |
   Caucasian | 9 (90) |
   Blacks/Asians | 1 (10) |
Prior therapy, n (%) | Â |
   Chemotherapy |  |
1 prior regimen | 4 (40) |
≥2 prior regimens | 6 (60) |
   Radiotherapy | 5 (50) |
   Immunotherapy | 0 (0) |
   Other | 1 (10) |
HLA-A2†, n (%) |  |
   Positive | 3 (30) |
   Negative | 7 (70) |